logo
Select company
Select metric
-15.06%EBITDA Margin
VS
Market
21
Sector
54
Industry
56
History
93
$ 6.44Close
$ 4.66 - $ 10.54 52-Week Range
Ticker Information

Ticker

TMCI

Company Name

TREACE MEDICAL CONCEPTS INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

TREACE MEDICAL CONCEPTS INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TMCI - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -32.19M-15.06%$ 213.75M
3/31/2025$ -36.43M-17.28%$ 210.82M
12/31/2024$ -39.72M-18.97%$ 209.36M
9/30/2024$ -47.13M-23.23%$ 202.86M
6/30/2024$ -48.72M-24.54%$ 198.53M
3/31/2024$ -40.79M-20.81%$ 196.03M
12/31/2023$ -36.55M-19.53%$ 187.12M
9/30/2023$ -35.6M-20.38%$ 174.68M
6/30/2023$ -31.19M-18.68%$ 166.97M
3/31/2023$ -36.97M-23.85%$ 154.99M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TREACE MEDICAL CONCEPTS INC's latest trailing twelve months (TTM) EBITDA % stands at 0.56%.
  • Over the past 5 years, TREACE MEDICAL CONCEPTS INC's average EBITDA % has been -20.13%.
  • The median EBITDA % for TREACE MEDICAL CONCEPTS INC during this period was -20.59%
  • TREACE MEDICAL CONCEPTS INC reached its highest EBITDA % over the past 5 years at 0.56%.
  • The lowest EBITDA % recorded by TREACE MEDICAL CONCEPTS INC in the same timeframe -29.8%

TREACE MEDICAL CONCEPTS INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
KIDS : ORTHOPEDIATRICS CORP -8.89%PACB : PACIFIC BIOSCIENCES OF CALIFORNIA INC -71.83%CERS : CERUS CORP -2.77%RXST : RXSIGHT INC -19.67%VMD : VIEMED HEALTHCARE INC 19.54%CTKB : CYTEK BIOSCIENCES INC 4.71%BFLY : BUTTERFLY NETWORK INC -59.32%QTRX : QUANTERIX CORP -50.82%DCTH : DELCATH SYSTEMS INC 2.19%OM : OUTSET MEDICAL INC -60.2%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for TREACE MEDICAL CONCEPTS INC is calculated as follows: EBITDA [ $ 319K ] / Revenues [ $ 57.37M ]
(=) EBITDA % [ 0.56% ]

TMCI - EBITDA Margin, Last 5 years

-29.8%

Minimum

Sep 30, 2022

0.56%

Maximum

Dec 31, 2020

-20.13%

Average

-20.59%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-75.07%
max97.73%
average16.12%
median14.72%
std26.88%